Back to BlackRock, Inc. BlackRock, Inc.

OVIDOVID
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in OVID THERAPEUTICS INC

BlackRock, Inc. holds 10.8M shares of OVID (OVID THERAPEUTICS INC), worth $29.1M as of 2026-Q2. The position was increased (+605.9% shares). OVID represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$29.1M

Current Shares

10.8M

Total Value Change

+$25.4M

Total Shares Change

+6.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10.8M
+605.9%
$29.1M0.0%$2.69
46
2026-Q1
Increased
1.5M
+149.9%
$3.4M0.0%$1.70
43
2025-Q4
Increased
613,475
+0.3%
$999,9640.0%$1.63
17
2025-Q3
Decreased
611,315
-55.4%
$794,7100.0%$1.40
0
2025-Q2
Decreased
1.4M
-64.5%
$451,6360.0%$0.30
0
2025-Q1
Decreased
3.9M
-1.8%
$1.2M0.0%$0.35
0
2024-Q4
New
3.9M
-
$3.7M0.0%$0.96
37

Other major holders of OVID: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used